Pharmacology
All Targets
7-TM Receptors
Ion Channels
Nuclear Receptors
Enzyme-Linked Receptors
Transporters
Enzymes
Other Pharmacology
Cellular Processes
Angiogenesis
Apoptosis
Cell Cycle
Cell Metabolism
Cytoskeleton & Motor Proteins
ECM & Adhesion Molecules
Epigenetics 
Signal Transduction
Stem Cells
Signaling Pathways
Product Type
All Products
New Products
Small Molecules
Peptides
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular System
Endocrinology
Immunology
Neuroscience
Pain & Inflammation
Respiratory System
Signal Transduction
Stem Cells
Signaling Pathways
Product Type
All Products
New Products
Small Molecules
Peptides
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular System
Endocrinology
Immunology
Neuroscience
Pain & Inflammation
Respiratory System
Non-selective / Other Potassium Channels
Inhibitors |
|
Cat.No. |
Product Name / Activity |
| 3891 | VU 590 dihydrochloride |
| Inhibitor of ROMK and Kir7.1 | |
Activators |
|
Cat.No. |
Product Name / Activity |
| 3797 | BL 1249 |
| Putative K2P2.1 (TREK-1) channel opener | |
Blockers |
|
Cat.No. |
Product Name / Activity |
| 4739 |
Cesium chloride
|
| Potassium channel blocker; neuroprotective | |
| 2330 | DMP 543 |
| K+ channel blocker and potent ACh release enhancer | |
| 3068 | Tetraethylammonium chloride |
| Non-selective K+ channel blocker | |
Other |
|
Cat.No. |
Product Name / Activity |
| 0416 | YS-035 hydrochloride |
| Inhibits K+ outward/pacemaker current | |
Quick Order
Find multiple products by catalog number
New Product E-alerts
Sign up for email updates from Tocris
20% Discount*
Potent, selective LRRK2 inhibitor
Tocris is the first to launch GSK2578215A, licensed from GlaxoSmithKline, for the study of Parkinson's Disease.